GENE ONLINE|News &
Opinion
Blog

Regulatory
Trials & Approvals Chronic Fibrosis
Boehringer Ingelheim’s Ofev Becomes First FDA Approved Treatment for Progressive Interstitial Lung Diseases
2020-03-11
Trials & Approvals Cystinosis
Investigational Gene Therapy for Cystinosis Obtains FDA’s Orphan Drug Designation
2020-03-10
COVID-19 Influenza
First Potential Treatment for COVID-19 Greenlighted by Korean Authorities
2020-03-08
Trials & Approvals Alzheimer's Disease
Spotlight: Shionogi’s Big Bet on Tetra Therapeutics
2020-03-07
Trials & Approvals PARP Inhibitor
GSK’s PARP Inhibitor, Zejula Gets Foot in the Door in EU to rival Rubraca and Lynparza
2020-03-06
Trials & Approvals
GSK’s Trelegy Ellipta, an Advanced Treatment for Asthma & COPD Submitted for EU Approval
2020-03-05
Trials & Approvals Anti-HIV
Kainos Medicine’s New HIV Drug Kicks Off Phase III Trial in China
2020-03-05
Trials & Approvals Acute Hepatic Porphyria
GIVLAARI to Enter European Market Following EMA Approval
2020-03-04
Trials & Approvals HER2 Inhibitor
NERLYNX-XELODA Combo Bags FDA Approval for HER2 Positive Breast Cancer Treatment
2020-02-27
Trials & Approvals Bacterial Infections
EXBLIFEP Surpasses Phase III, Presents Novel Solution for Antibiotic Resistance Crisis in Treating Complicated UTI
2020-02-26
Trials & Approvals Cholesterol
FDA Approval of Cholesterol Lowering Drug, NEXLETOL, A Value-Add to Existing Treatments
2020-02-25
Trials & Approvals
Relief for Patients as Baudax Bio’s Non-Opioid Analgesic Wins FDA Approval
2020-02-23
Trials & Approvals Depression
VistaGen’s Antidepressant Nasal Spray Succeeds Phase 2a Trial
2020-02-22
Trials & Approvals
VEGF Inhibitor, Beovu Gets EC Approval for Wet Age-Related Macular Degeneration Treatment
2020-02-18
Trials & Approvals Multiple Myeloma
GSK Wins EMA Approval to Market Multiple Myeloma Treatment
2020-02-16
1 … 47 48 49 50 51 … 53
LATEST
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top